American Association for Cancer Research

2011 Minority Scholar in Cancer Research Awards M-Z

 Sydika McKissic

Sydika McKissic, B.S.
Vanderbilt University, Nashville, TN

“After completing my Ph.D. training, I plan on pursuing a postdoctoral training fellowship in translational cancer research. My career objective is to be an independent investigator in cancer research, with an emphasis on translating laboratory-based discoveries into effective therapeutics. In addition, I plan on developing and implementing science programs targeting minority youth.”

Abstract #2401 Loss of Nkx3.1 cooperates with Myc overexpression to promote prostate tumorigenesis. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Room W311 E-F

 Christina Medina-Ramirez

Christina M. Medina-Ramirez, Ph.D.
Albert Einstein College of Medicine, Bronx, NY

“My decision to continue my postdoctoral training in cancer research is based on my desire to become an independent investigator in either academia or government. As I evolve my independent research plan, I would like to ask more translational questions that address individualized cancer therapies. In addition to my scientific goals, I am committed to having a career that includes substantial teaching and mentorship. Furthermore, I intend to use my position as a Latina scientist to advocate for programs that provide underrepresented minority students access to research careers."

Abstract #4695 Apoptosis inhibitor ARC as a novel mediator of breast tumorigenesis, metastasis and chemoresistance. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Room W311 E-F

 Diana Merino

Diana M. Merino, M.S.
Hospital for Sick Children, Toronto, ON

"My goals are to become a proactive researcher in the field of cancer genetics, answering questions that will contribute to the global fight against cancer, and to lead a group of researchers in this task as a principal investigator. I plan on learning from my own research experience as well as from others’ by interacting with fellow researchers at events such as the annual AACR meetings, in which I will obtain a greater scope on the way these questions are being answered."

Abstract #3460 Genome-wide copy number analysis reveals novel somatic mutations associated with choroid plexus tumorigenesis. Poster Session: Monday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Fassil Mesfin

Fassil B. Mesfin, M.D., Ph.D.
Albany Medical College, Albany, NY

“My personal long-term goal is a career as an independent cancer researcher at a major university. During traineeship, I intend to continue to enrich my knowledge of CNS cancer by conducting research, publishing, teaching and, most importantly, caring for patients.”

Abstract #562 Multi-Kinase Inhibitor: AFPep inhibits the growth and invasion of U87 glioblastoma cells through inhibition of FAK, MAPK, and PKC. Poster Session: Sunday, April 3, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Brenda Montalvo-Ortiz

Brenda L. Montalvo-Ortiz, Ph.D.
University of Puerto Rico Medical Sciences Campus, San Juan, PR

“My long-term goal is to become an independent investigator in the cancer field. My future career objectives are orientated towards applying my multidisciplinary knowledge to translational research. I have knowledge in chemistry, biochemistry, molecular and cell biology, design and screening of drugs and drug delivery systems. By combining all of my research expertise, I plan to develop new drugs for the treatment of cancer and formulate novel delivery systems for targeted therapy.”

Abstract #3251 Characterization of a novel Rac inhibitor as an anti cancer metastasis compound. Poster Session: Monday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Jeremy Myers

Jeremy N. Myers, Ph.D.
Meharry Medical College, Nashville, TN

“After I finish the Ph.D. program here at Meharry I hope to continue my training in the cancer field by completing a postdoctorate in bioinformatics. I am dedicated to teaching as well, therefore, I would like to teach/guide minority students in the methods of scientific reasoning and research. In the future I would like to start an organization that will provide opportunities for underrepresented minority groups to develop as scientists.”

Abstract #1334 Benzo(a)pyrene metabolic pathway-dependent DNA damage in HT-29 colon cells. Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Margaret Ndinguri

Margaret Ndinguri, Ph.D.
University of Texas Health Science Center, San Antonio, TX

“My long-term goal is to become a principal investigator in cancer research, especially in the area of drug targeting.”

 Chane O'Bannon

Chané O’Bannon, B.S.
Loma Linda University, Loma Linda, CA

“I study the estrogen receptor and would like to understand its functional role in breast cancer development and resistance. I plan to continue doing research and maybe even teach one day. I would like to make any contribution to the body of knowledge that already exists in order to get one step closer to understanding the disease.”

Abstract #1114 IGF-II regulates the expression of estrogen receptor beta 5: Role in the survival disparity between African-American and Caucasian women with breast cancer. Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Coral Omene

Coral O. Omene, M.D., Ph.D.
NYU Langone Medical Center, New York, NY

“My long-term plans are to continue work in the fields of breast cancer biology and developmental therapeutics, and to combine my scientific background and clinical training to address specific issues revolving around the ethnic differences impacting breast cancer biology and choice of therapeutic options.”

Abstract #3344 CAPE-induced inhibition of breast cancer stem cells (CSC) self-renewal and growth by differentiation to a less malignant phenotype. Poster Session: Tuesday, April 5, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Joyce Osanyingbemi-Obidi

Joyce Osanyingbemi-Obidi, B.S.
Johns Hopkins University, Baltimore, MD

“Upon completion of my doctoral degree at Johns Hopkins, I plan to continue my career in the field of oncology; more specifically in drug discovery, drug regulation and eventually drug assessment via clinical trials. I am drawn by the complexity of the disease but more importantly by the urgency to find more effective therapeutics.”

Abstract #5209 The roles of notch signaling in the development of non-small cell lung cancer. Poster Session: Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Mahasin Osman

Mahasin Osman, Ph.D.
Brown University, Providence, RI

"In addition to the basic cell biology projects in my lab, I am currently developing a research program in cancer health disparity. The over-arching goal is to determine signaling dysfunction in cancer development and progression and identify molecular markers for early detection and rational therapeutics.”

 Yolanda Pina

Yolanda Pina, B.S.
Bascom Palmer Eye Institute, Miami, FL

“My goal is to complete a medical degree and specialize in neurology, as well as to continue my research studies in biomedical research and cancer.”

Abstract #2050 2-Deoxy-D-Glucose (2-DG) as a glycolytic inhibitor in the treatment of retinoblastoma. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C 

Abstract #3865 Regional and temporal variations in gene expression and vasculature during retinoblastoma tumorigenesis and its impact on ocular treatment. Poster Session: Tuesday, April 5, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C 

Abstract #1517 Retinoblastoma tumor development: Role of tumor-associated macrophages and their sub-type in LHBETATAG retinal tumor progression. Poster Session: Monday, April 4, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #5352 Novel treatment approaches in retinoblastoma: Impact of combination therapy on tumor burden. Poster Session: Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Ramona Salcedo Price

Ramona Salcedo Price, B.S.
The University of Texas at Austin, Austin, TX

“My long-term career goals include becoming an independent, highly productive and collaborative prostate cancer research scientist and professor at an academic research institution. My expectation is to contribute to prostate cancer survivorship among obese men. My goal is to obtain and maintain research funding. Upon completion of the Ph.D. program at UT Austin, I anticipate applying for an NIH/NCI fellowship to obtain a Master of Public Health degree followed by a postdoctoral position in prostate cancer research at an academic institution.”

Abstract #971 Obesity initiates a self-perpetuating inflammatory response in LNCaP prostate cancer cells. Poster Session: Sunday, April 3, 2011, 3:15 p.m. - 5:15 p.m., Orange County Convention Center, Room W224 C/D/G/H

 Delira Robbins

Delira F. Robbins, B.S.
Louisiana State University Health Science Center in Shreveport, Shreveport, LA

“After completing my Ph.D. training, I plan to pursue a postdoctoral position at an institution that integrates drug discovery with basic science research. Overall, my long-term goal is to complete my postdoctoral training in pharmacology with an emphasis on understanding ROS-induced epigenetic modifications that lead to silencing of tumor suppressor genes. Upon completion, I would like to pursue a career in drug development, while continuing to serve as a mentor to underrepresented minority communities.”

Abstract #207 PTEN contributes to p53 activation during skin transformation. Poster Session: Sunday, April 3, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Johnny Sena

Johnny A. Sena, M.S.
University of Colorado Denver Anschutz Medical Campus, Aurora, CO

“Over my career I would like to see cancer as a curable disease. I believe that my hard work and training at UC Denver will allow me to have my own laboratory in an academic institution in the future. Additionally, I hope that my research will give the scientific community a better understanding of the environmental factors that promote tumor growth and identify targets to better treat cancers.”

Abstract #2048 USF2 is HIF2α specific co-transcriptional activator. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C 

 Randolph Stone

Randolph Stone II, B.S.
Louisiana State University Health Science Center in Shreveport, Shreveport, LA

“My ultimate career goal is to carry out cancer-related biomedical and behavioral research as an independent scientist. My immediate goal is to graduate with a Ph.D. in biochemistry and then move on to a postdoctoral position, further learning and enhancing the necessary skills to be an independent researcher.”

Abstract #4861 Identification of premalignant bladder markers using DNA microarray analysis of the UPII-SV40Tag model for invasive bladder UCC. Poster Session: Tuesday, April 6, 2011, 8:00 p.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Aron Tesfamichael

Aron Tesfamichael, Ph.D.
Clark Atlanta University, Atlanta, GA

“The use of cancer cells in biomedical research offers the potential for significant advances in the next decades, provided investigators not only understand this potential, but are equipped to take advantage of it. My goal is to be part of this investigation by establishing my own laboratory or working in a pharmaceutical company to contribute something to the world.”

 Mathewos Tessema

Mathewos Tessema, Ph.D.
Lovelace Respiratory Research Institute, Albuquerque, NM

“My immediate career goal is to establish myself as an outstanding, highly competitive, independent researcher. My long-term career goal is to make important contributions that could improve the diagnosis, treatment and prevention of cancer through identification of risk factors, early diagnostic and prognostic markers as well as targets for the treatment and prevention of this devastating disease.”

Abstract #87 SULF2 methylation is a prognostic biomarker for lung cancer survival and increases sensitivity to camptothecin analogues via expression of ISG15. Poster Session: Sunday, April 3, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Jose Trevino

José G. Treviño, M.D.
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

"My short and long-term educational and research goals involve finishing my last year of subspecialty training and begin a junior faculty career in surgical oncology where I hope to perform independent translational basic science cancer research. I believe my education and training have given me the opportunity to be competitive for peer-reviewed funding and continue with goals to continue to collaborate with fellow basic scientists and clinicians in the fight against cancer."

Abstract #2590 Selective disruption of Rb-Raf-1 kinase interaction is a suitable therapeutic option for pancreatic adenocarcinoma. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #4993 Nicotine induced EMT and metastasis of human NSCLC : Role of beta-arrestin-1. Poster Session: Wednesday, April 6, 2011, 8:00 a.m. - 12:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #4381 EGFR-Src signaling regulates self-renewal of cancer stem like cells from NSCLC through Sox2. Poster Session: Tuesday, April 5, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

Abstract #1972 Nicotine regulates DNA-binding protein inhibitor (Id1) through a Src-dependent pathway promoting tumorigenic properties and chemoresistance in pancreatic adenocarcinoma. Poster Session: Monday, April 4, 2011, 1:00 p.m. - 5:00 p.m., Orange County Convention Center, Exhibit Hall A4-C

 Tonya Webb

Tonya J. Webb, Ph.D.
University of Maryland School of Medicine, Baltimore, MD

“My long-range goal is to become a well-established, fully funded leading research in the field of cancer immunology. My career objectives are to work to develop novel immunotherapeutic strategies for the treatment of melanoma, breast, lymphoma and prostate cancers, and to successfully train and mentor young scientists so that they can achieve their educational and career goals.”

 

 Danyell Wilson

Danyell S. Wilson, Ph.D.
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

“My interests include developing science learning tools and methodologies for all ages that can be used in culturally informal learning environments (health fairs, community events, town hall meetings, public libraries) to create awareness of scientific research, education, discoveries, programs and careers as they relate to reducing cancer health disparities in underrepresented communities.”

 

 

Awardees A-L

Back to top